David Gratton

1.6k total citations
22 papers, 724 citations indexed

About

David Gratton is a scholar working on Dermatology, Immunology and Immunology and Allergy. According to data from OpenAlex, David Gratton has authored 22 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Dermatology, 7 papers in Immunology and 5 papers in Immunology and Allergy. Recurrent topics in David Gratton's work include Dermatology and Skin Diseases (11 papers), Psoriasis: Treatment and Pathogenesis (6 papers) and Acne and Rosacea Treatments and Effects (5 papers). David Gratton is often cited by papers focused on Dermatology and Skin Diseases (11 papers), Psoriasis: Treatment and Pathogenesis (6 papers) and Acne and Rosacea Treatments and Effects (5 papers). David Gratton collaborates with scholars based in Canada, United States and United Kingdom. David Gratton's co-authors include Karen Willcox, Vincent Ho, W.J. Cunliffe, Colin A. Holden, W. Stuart Maddin, J. Berth‐Jones, Jean-Paul Ortonne, A Claudy, Daniel N. Sauder and K. Kalimo and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of the American Academy of Dermatology and Clinical Therapeutics.

In The Last Decade

David Gratton

22 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Gratton Canada 15 510 260 197 78 75 22 724
John Toole Canada 11 276 0.5× 241 0.9× 6 0.0× 85 1.1× 42 0.6× 18 610
Elena Niculeț Romania 12 146 0.3× 105 0.4× 15 0.1× 123 1.6× 86 1.1× 58 518
Mai-Szu Wu Taiwan 11 80 0.2× 61 0.2× 23 0.1× 24 0.3× 26 0.3× 18 469
Adel Sammain Germany 8 596 1.2× 78 0.3× 5 0.0× 250 3.2× 15 0.2× 15 712
Mona A. Gandhi United States 15 158 0.3× 61 0.2× 8 0.0× 111 1.4× 32 0.4× 32 645
Vipul V. Jain United States 14 46 0.1× 314 1.2× 167 0.8× 77 1.0× 5 0.1× 26 851
Rudra Prosad Goswami India 16 44 0.1× 126 0.5× 10 0.1× 251 3.2× 244 3.3× 52 787
Lisheng Zheng China 11 32 0.1× 50 0.2× 23 0.1× 63 0.8× 21 0.3× 35 564
Manjunath Shenoy India 12 130 0.3× 29 0.1× 12 0.1× 300 3.8× 40 0.5× 81 496
Noguchi Japan 8 31 0.1× 166 0.6× 48 0.2× 32 0.4× 8 0.1× 27 453

Countries citing papers authored by David Gratton

Since Specialization
Citations

This map shows the geographic impact of David Gratton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gratton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gratton more than expected).

Fields of papers citing papers by David Gratton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gratton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gratton. The network helps show where David Gratton may publish in the future.

Co-authorship network of co-authors of David Gratton

This figure shows the co-authorship network connecting the top 25 collaborators of David Gratton. A scholar is included among the top collaborators of David Gratton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gratton. David Gratton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Levy, Adrian R., et al.. (2012). Economic burden of moderate to severe plaque psoriasis in Canada. International Journal of Dermatology. 51(12). 1432–1440. 45 indexed citations
3.
Gratton, David. (2011). Reversible Posterior Leukoencephalopathy Syndrome in a Patient Treated With Ustekinumab. Archives of Dermatology. 147(10). 1197–1197. 33 indexed citations
4.
Tan, Jerry, Richard Thomas, Béatrice Wang, et al.. (2009). Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis.. PubMed. 83(3). 157–64. 10 indexed citations
5.
Toth, Darryl, Kim Papp, & David Gratton. (2008). Long-term efficacy of up to 15 months’ efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasis. Dermatologic Therapy. 21. S6–S14. 4 indexed citations
6.
Lynde, Charles, Kirk Barber, Joël Claveau, et al.. (2005). Canadian Practical Guide for the Treatment and Management of Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery. 8 Suppl 5. 1–9. 17 indexed citations
7.
Goffe, Bernard S., Kim Papp, David Gratton, et al.. (2005). An integrated analysis of thirteen trials summarizing thelong-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy. Clinical Therapeutics. 27(12). 1912–1921. 44 indexed citations
8.
Cunliffe, W.J., F. William Danby, Frank Dunlap, et al.. (2003). Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.. PubMed. 12(4). 350–4. 29 indexed citations
9.
Reitamo, Sakari, E.J.M. van Leent, Vincent Ho, et al.. (2002). Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. Journal of Allergy and Clinical Immunology. 109(3). 539–546. 171 indexed citations
10.
Marcoux, Danielle & David Gratton. (2002). The Changing Face of Canadian Dermatology. Journal of Cutaneous Medicine and Surgery. 6(5). 430–433. 2 indexed citations
11.
Marcoux, Danielle & David Gratton. (2002). The Changing Face of Canadian Dermatology. Journal of Cutaneous Medicine and Surgery. 6(5). 430–433. 1 indexed citations
12.
Berberian, Brenda J., Debra Breneman, Lynn A. Drake, et al.. (1999). The addition of topical doxepin to corticosteroid therapy: an improved treatment regimen for atopic dermatitis. International Journal of Dermatology. 38(2). 145–147. 27 indexed citations
13.
Gratton, David. (1998). The many faces of rosacea.. PubMed. 2 Suppl 4. S4–2. 2 indexed citations
14.
Ho, Vincent, Martin Cloutier, David Gratton, et al.. (1997). Neoral® in the Treatment of Psoriasis: Consensus Treatment Guidelines. Journal of Cutaneous Medicine and Surgery. 1(4). 209–215. 3 indexed citations
15.
Patel, Piyush M., et al.. (1997). A double-blind study of loratadine and cetirizine in atopic dermatitis. Journal of Dermatological Treatment. 8(4). 249–253. 10 indexed citations
16.
Cunliffe, W.J., J. Berth‐Jones, A Claudy, et al.. (1992). Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. Journal of the American Academy of Dermatology. 26(5). 736–743. 145 indexed citations
17.
Winkelman, Warren & David Gratton. (1989). Topical antibacterials. Clinics in Dermatology. 7(3). 156–162. 18 indexed citations
18.
Gratton, David. (1987). Topical Mupirocin Versus Oral Erythromycin in the Treatment of Primary and Secondary Skin Infections. International Journal of Dermatology. 26(7). 472–473. 22 indexed citations
19.
Côté, Jean, Michel Trudel, & David Gratton. (1983). T cell chronic lymphocytic leukemia with bullous manifestations. Journal of the American Academy of Dermatology. 8(6). 874–878. 15 indexed citations
20.
Gratton, David, et al.. (1982). Topical clindamycin versus systemic tetracycline in the treatment of acne. Journal of the American Academy of Dermatology. 7(1). 50–53. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026